StockWatch
·

20 MICRONS LTD. Q2 FY27 Results

20MICRONSQ2 FY27 Results
Filing
Result:Weak· Market: Crashed#Margin squeeze#Cost led

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue238.162.7%3.2%
Total Income239.472.7%3.1%
Expenditure220.010.7%5.3%
PBT19.4620.4%17.1%
Net Profit13.6423.1%21.4%
OPM11.64%1.60pp2.16pp
NPM5.70%1.51pp1.77pp
EPS3.8723.2%21.3%
View full financials

Revenue grew just 3.2% YoY while adjusted PAT fell 21.4% on cost-led margin compression (OPM 11.6% vs 13.8%), missing management's own growth/margin guidance with no offsetting one-off or base effect.

20 MICRONS LIMITED · Q2 FY-2027 · THE VERDICT

Growth stalls, energy bleeds margins — the long-term bet wears thin

Management reaffirmed an 18% CAGR and margin-expansion roadmap, but Q2 delivered only 3.2% revenue growth and a 21.4% profit decline. A ₹4.78 crore energy and freight cost shock masks the underlying deterioration, and the market has already priced in skepticism.

02 Nov 2026 · 6 min read
Revenue

₹238.16 Cr

+3.2% YoY vs 18% CAGR guidance

EBITDA

₹27.73 Cr

11.6% margin, -200 bps YoY

Net profit

₹13.64 Cr

-21.4% YoY, -23.1% QoQ

On paper, 20 Microns delivered a 3.2% revenue growth and a 21.4% profit decline in Q2 — a quarter that was supposed to mark the company's return to momentum after two weak quarters. But the real story is simpler and more sobering: a ₹4.78 crore energy and freight cost shock — power up 33%, gas up 77%, freight up 11% — crushed operating leverage, and management's long-term hedges (solar plants, captive mines) remain years away from yielding relief.

The margin trap

Gross margin held firm at 47.7%, up a hair from 47.6% a year ago. That steadiness is real — it reflects a genuine shift toward specialty products, where 20 Microns now sources roughly one-third of revenue at higher markups. But the moment you descend to operating profit, the picture inverts: EBITDA margin fell 200 basis points to 11.6% from 13.8% a year prior, and net margin slid 150 bps to 5.7% from 7.2%. The culprit is unhedged input-cost inflation: power costs per kilogram rose from ₹42 to ₹56 (+33%), furnace gas from ₹69 to ₹122 per unit (+77%), and freight from ₹2,100 to ₹2,300 per metric tonne (+11%). In aggregate, that's a ₹4.78 crore drag on EBITDA — or roughly 200 basis points of the margin compression. None of that headwind has been hedged, and none is expected to reverse near-term.

Power costs ₹42→₹56/kg (33%, ₹1.34 Cr). Gas ₹69→₹122/kg (77%, ₹0.62 Cr). Freight ₹2.1→₹2.3K/MT (11%, ₹2.92 Cr). Total ₹4.78 Cr (200 bps). Solar will meet 40% of power by FY29, worth ~₹8 Cr EBITDA/yr.

What management said; what holds up

The four key claims on the call — and the reality behind them

Revenue growth returned in Q2; we're back on track to an 18% CAGR.

3.2% YoY growth delivered, vs an 18% CAGR target. That's a 1.8x shortfall. At 3.2% annual growth, the company would reach only 7.6% cumulative CAGR over three years, not 18%. No path to 18% is visible without major acceleration.

Contradicted

Gross margin rose ~80 bps for the half; specialty products are now driving mix uplift.

Q2 gross margin at 47.7% vs 47.6% YoY — essentially flat, not expanding. Specialty product shift is real (now ~1/3 of revenue), but the mix lift is fully offset by unhedged energy and freight inflation. Operating margin fell 200 bps.

Overstated

The 18% CAGR is definitely achievable with CapEx and mining ramp.

Reaffirmed but hedged as 'should help us regain' — a retreat from prior confident tone. No near-term targets quantified. December mine start and Q4 solar commissioning still ahead; benefits deferred to FY29. Contingency language suggests management knows the near-term looks weak.

Supported but hedged

Specialty products are now ~1/3 of revenue with better margins; this mix shift is the real story.

Analyst estimate of 1/3 confirmed; high-margin grades (polymers, rubber, construction chemicals) growing double-digit per management. But PAT margin compressed YoY despite the mix shift. Specialty uplift not yet visible in group profitability — energy inflation is eating the gain.

Mixed

What changed on this call

  • Revenue growth guidance credibility eroded. Reaffirmed 18% CAGR but hedged as 'should help us regain' vs. prior definitive tone. Q2 delivered 3.2% YoY; no near-term acceleration visible.

  • Margin expansion guidance quietly dropped. Prior calls promised 200–250 bps EBITDA margin uplift within three years. This call did not reaffirm that target. Solar's ₹8 Cr annual benefit (80 bps) deferred to FY29. Near-term margin relief off the table.

  • CapEx transparency improved. Specific project names now disclosed: talc mine (Andhra Pradesh, ₹7 Cr), quartz/feldspar mine (Rajasthan, ₹7 Cr), 9 MW solar split across two plants (Rajasthan 5.5 MW, Gujarat 3.5 MW, ₹29 Cr), Malaysia specialty capacity expansion (ongoing). 30% deployed; remaining 70% over next 15–18 months.

  • Energy hedging remains absent. No disclosure of forward contracts, commodity futures, or insurance mechanisms to offset power/gas/freight inflation. Management focused on long-term mitigation (captive solar, mining) but left Q3–Q4 exposed.

The debate

The bull-bear ledger

  • Named ₹100 Cr CapEx with 30% deployed and project timelines disclosed (solar, mining, Malaysia)

  • Specialty product mix accelerating (polymers, rubber, construction chemicals all double-digit); 250+ grades now in portfolio

  • Gross margin resilience at 47.7% despite 33% power inflation and 77% gas inflation shows product mix shift is real

  • 25-year customer relationships and DSIR-recognised R&D centre create competitive moat

  • Reported profit leans 100% on cost inflation narrative; no operational improvement visible

  • Q2 revenue +3.2% YoY vs 18% CAGR guidance — 1.8x shortfall with no visible path to acceleration

  • Paint segment (largest) flat YoY; customers raising retail prices but wholesale constrained — pricing power absent

  • Energy and freight cost inflation (₹4.78 Cr) unhedged; no forward contracts or insurance disclosed

  • All margin and growth upside deferred to FY29; near-term deterioration risk is material

  • FII ownership down to 0.41%, DII down to 0.07% — institutional disengagement accelerating

Risks, ranked by severity to a holder

The key risks that could derail the story

Energy and freight inflation persists unhedged

High

₹4.78 Cr (200 bps EBITDA) hit Q2 with zero forward contracts or hedges disclosed. If oil, LNG, and freight stay elevated through Q3–Q4 FY27, EBITDA margins could compress below 10%. Solar plants won't be live until Q4 FY27 at earliest. The company is naked to commodity exposure for another 6+ months.

Revenue growth stalls despite specialty product narrative

High

3.2% YoY growth is structurally weak. Paint (largest segment) flat YoY despite price hikes. Specialty products (polymers, rubber) growing double-digit but not yet moving group revenue needle. If paint demand stays subdued and specialty uplift slows, the 18% CAGR target becomes impossible.

CapEx execution slips on mining ramp or solar commissioning

Medium

December 2026 talc/quartz mine start and Q4 FY27 solar commissioning are the near-term catalysts. Any delay cascades: margin benefits pushed to FY28 or FY29, credibility further eroded, stock likely re-rates lower. The company has one shot to hit these timelines.

Raw-material import dependence (40%) amplifies geopolitical/tariff risk

Medium

China, Malaysia, Vietnam supply 40% of inputs. Tariff escalation, supply disruptions, or currency moves could spike costs further. Mining acquisitions will reduce import share to ~30% by FY29, but until then the company is exposed.

Pricing power remains capped by B2B pass-through limits

Medium

Paint customers raised retail prices 3x in six months but constrain wholesale increases to 20M. Polymers, rubber, and specialty customers also cap pass-through. If input costs re-accelerate, margin compression will resume even with specialty mix uplift.

Institutional ownership collapse signals deeper skepticism

Medium

FII down to 0.41% from prior 0.88%, DII down to 0.07% from 0.18%. Smart money is exiting or staying away. If institutions continue to trim, equity-market liquidity could suffer and re-rating lower could accelerate.

How the street is positioned — and what it means

The market has already rendered its verdict, and it's blunt: ₹162.85, down 53% from the all-time high of ₹346.7, and trading below every major moving average (SMA20 ₹186.6, SMA50 ₹202.84, SMA200 ₹186.63). The 52-week range is ₹130.5 to ₹238.1; the stock is now trading near its lows. Volume is increasing on the way down — a sign of institutional capitulation, not accumulation.

Ownership tells the same story: FII has shrunk to 0.41% from 0.88% a year ago, and DII is near-zero at 0.07% (down from 0.15–0.18% prior). Promoters still own 45%, but the lack of institutional interest is a red flag. Block-deal activity over the past six months shows mostly even buys and sells — no standout accumulation by marquee buyers, no signs of insider conviction. The stock is in the wilderness, and the earnings call did nothing to pull it back.

That said, the valuation discount is real. At current price, 20 Microns is trading at a trough multiple relative to its long-term ROIC target (18–20%) and the CapEx programme's expected IRR. But discounts persist for reasons: the market is pricing in two more quarters of weak growth and margin pressure before any catalyst fires. The Dec 2026 mine start and Q4 FY27 solar commissioning are the pivots — if those slip, the stock could trade lower still.

What to watch next

Three concrete triggers that resolve the debate
  • 1 · Q3 FY27 (Dec 2026): Mining ramp and CapEx progress

    Talc and quartz mines must start production as promised. CapEx should reach 50% deployed (₹50 Cr), with no schedule slippage. Any delay or cost overrun here signals execution risk and validates the bear case.

  • 2 · Q4 FY27 (Mar 2027): Solar commissioning and margin guidance

    9 MW captive solar plants must go live. Management must quantify the EBITDA benefit and commit to a near-term (FY28–FY29) margin expansion target. Vague language on timing or magnitude will further erode credibility.

  • 3 · FY28 run-rate (Apr 2027–Mar 2028): Revenue acceleration and specialty product contribution

    Specialty products must move from 'growing but not visible in group PAT' to a material margin contributor. Revenue growth must show signs of acceleration toward double-digits. If specialty uplift remains opaque and growth stays below 5%, the long-term narrative collapses.

20 Microns is in the midst of a multi-year CapEx and operational transformation. The pieces are named, the timelines are concrete, and the long-term ROCE uplift (to 18–20%) is plausible if execution holds. But the near-term is deteriorating: growth is stalled at 3.2% YoY, margins are compressed 200 bps by unhedged energy inflation, and all upside is deferred to FY29. Management reaffirmed the long-term narrative but hedged on near-term specifics — a signal of awareness that the path is narrowing.

The market has already priced in skepticism: the stock is down 53% from ATH, institutional ownership is collapsing, and volume is rising on the way down. The honest read is that this is a steady-execution story, not a step-change. A Hold is warranted: accumulate only on clear signs that the December mine ramp and Q4 solar commissioning are tracking, and that specialty product margin contribution is accelerating. The single number to track from here is organic revenue growth recovery — if that stays below 5% into FY28, the 18% CAGR target is a fantasy.

Informational and educational content only. Not investment advice.